Liposomal-lipopolysaccharide vaccine extracted from Proteus mirabilis induces moderate TLR4 and CD14 production Cover

.blurhash-client-img { display: none !important; }

Liposomal-lipopolysaccharide vaccine extracted from Proteus mirabilis induces moderate TLR4 and CD14 production

Current Issues in Pharmacy and Medical Sciences

Volume 32 (2019): Issue 2 (June 2019)

By: Ruaa SH. Nile, Mayyada F. Darweesh and Mohauman M. Al-Rufaie

Open Access

|Jul 2019

Authors

Ruaa SH. Nile

Department of Biology, Faculty of Science, Kufa University, Najaf, Iraq

Mayyada F. Darweesh

mayadajalala@yahoo.com

Department of Biology, Faculty of Science, Kufa University, Najaf, Iraq

Mohauman M. Al-Rufaie

Department of Biology, Faculty of Science, Kufa University, Najaf, Iraq

DOI: https://doi.org/10.2478/cipms-2019-0016 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X

Journal RSS Feed

Language: English

Page range: 81 - 86

Submitted on: Apr 10, 2018

|

Accepted on: Jul 6, 2018

|

Published on: Jul 2, 2019

Published by: Sciendo

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Lipopolysaccharide,

Proteus mirabilis,

immunomodulater activity,

Related subjects:

Clinical medicine,

Clinical medicine, other,

Pharmacology, toxicology,

Pharmacy, other

© 2019 Ruaa SH. Nile, Mayyada F. Darweesh, Mohauman M. Al-Rufaie, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 32 (2019): Issue 2 (June 2019)Next article